2020
DOI: 10.1016/j.kisu.2019.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Global case studies for chronic kidney disease/end-stage kidney disease care

Abstract: T he prevalence of chronic kidney disease (CKD) and its risk factors is increasing worldwide, and there is a rapid rise in global need for the treatment of end-stage kidney disease (ESKD). The global nephrology community recognizes the need for a plan to address the growing incidence of CKD and a cohesive approach for CKD/ESKD integrated care. 1 This provides a major challenge for health systems, particularly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
76
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 78 publications
(81 citation statements)
references
References 56 publications
0
76
0
5
Order By: Relevance
“…There is a need for further primary research on the effect of PC integrated care on patients with CKD that follows a uniform standard of data collection. The challenge is to develop a uniform and universal PC integrated care model that incorporates the interrelated co-morbidity factors that underlie the burden of CKD [ 72 , 73 , 74 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There is a need for further primary research on the effect of PC integrated care on patients with CKD that follows a uniform standard of data collection. The challenge is to develop a uniform and universal PC integrated care model that incorporates the interrelated co-morbidity factors that underlie the burden of CKD [ 72 , 73 , 74 ].…”
Section: Discussionmentioning
confidence: 99%
“…The lack of an organized and uniform method of data collection specifically focused on PC integrated CKD care management resulted in a marked lack of high-quality evidence available for literature reviews [ 74 ]. There was a lack of data available for organization-level care integration, methodologic limitations that reduced the confidence of data, a lack of long-term studies with follow-up beyond 12 months, and a lack of significant statistical values due to small sample sizes and low-quality data [ 72 ].…”
Section: Discussionmentioning
confidence: 99%
“…In-center HD was the predominant KRT modality in most countries and it accounted for more than 80% of dialysis in 79% of countries in 2016 [3]. Several countries and regions have initiated PD-First policies or PD-Favored policies to encourage the use of PD as the first treatment modality for appropriate patients because PD is deemed to have lower costs than HD, comparable survival and improved quality of life (QOL) [9][10][11][12]. Accordingly, higher rates of PD uptake were reported in those countries and regions, such as Hong Kong (71%), the Jalisco region of Mexico (61%), and Guatemala (57%) [3].…”
Section: Introductionmentioning
confidence: 99%
“…Proposed activities included data capture, policy creation, definition of quality standards, evidence-based guidance, capacitybuilding, implementation, and research, as well as a performance measurement framework to assess progress. [3][4][5][6][7][8][9][10][11][12][13] In parallel, the ISN is working with the World Health Organization (WHO) to develop a technical package for those wishing to start or expand dialysis services.…”
mentioning
confidence: 99%